Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05456113Withdrawn
Trial of cannabidiol in pain (2 arms), sponsored by The Pennsylvania State University. Primary endpoint: Cutaneous Vascular Conductance at 5 hours. Planned start Dec 2024; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05456113.